April 1, 2010
Joffe appointed to federal committee

Steven Joffe, MD, MPH
Steven Joffe, MD, MPH, a pediatric hematologist/oncologist at Dana-Farber and Children's Hospital Boston, was recently appointed to the U.S. Department of Health and Human Service Secretary's Advisory Committee on Human Research Protections. This 11-member committee advises the secretary on all issues related to research, ethics, and regulation, such as best practices in informed consent, the process in which a patient learns about and understands the purpose, risks, and benefits of a clinical trial before agreeing to participate in it, and obligations for sharing discoveries with research subjects.
Joffe's work focuses on the ethical challenges of human subject research, particularly pediatric research ethics, cancer clinical trials, ethical aspects of research design, and conflict of interest. For example, if a parent approves the storage of a child's tumor in a research tissue bank, when the child becomes an adult, do researchers need to reconsent to use the tissue for research?
Susan Kornetsky, director of Clinical Research Compliance at Children's Hospital, and a former member of the committee, says Joffe's pediatric experience makes him a good choice for the appointment as someone who can raise flags regarding the differences in adult and pediatric research.
Others agree. "Pediatric representation on federal oversight committees is critical to providing the perspective of both pediatrics and academic medical centers that focus on childhood diseases in government decisions," says David Williams, MD, chief of the Division of Hematology/Oncology and director of Translational Research at Children's Hospital. "In many cases, the representation provides a unique point of view that is important in advocating for measures that facilitate the interests of the family as a whole and research into pediatric conditions."
News
DF/CHCC ranks best in New England, tops in country
For the third year in a row, Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) was ranked the number one pediatric cancer program in New England, and one of the best in the country in U.S. News & World Report's 2010-2011 Best Children's Hospitals issue. read more
Upcoming Events
Join us at SIOP Boston 2010
Dana-Farber/Children's Hospital Cancer Center is proud to welcome the 42nd Congress of the International Society of Paediatric Oncology (SIOP) to Boston, October 21-24, 2010. SIOP features an exciting scientific and social agenda for all members of the pediatric oncology community, including oncologists, surgeons, radiotherapists, pathologists, nurses, basic scientists, epidemiologists, biostatisticians, psychologists, and parents and survivors. Don't miss this opportunity to interact with your the global colleagues. Visit www.siopboston2010.com and register today.

